Thank you for your interest in our Health Professional Resource section which includes helpful tools, educational resources, and in depth research and information about the SFI Health range.
In accordance with TGA policies, access to our health professional content will only be granted to practitioners registered with a professional association.
Students: Once you complete this form please send proof that you are student to practitioners@sfihealth.com so that we can approve your registration.
Saccharomyces boulardii (SB) is a probiotic yeast clinically researched for use in several gastrointestinal disorders. This article examines the evidence for the use of SB in cases of antibiotic associated diarrhoea.
The widespread prevalence of antibiotic use in Australia presents a concern for adverse effects commonly experienced, particularly resulting from alterations to the gastrointestinal microbiome.
Co-prescribing antibiotic resilient probiotics with antibiotic therapy can ameliorate such adverse effects and benefit digestive and immune functions of the healthy intestinal microbiome. Read here to learn more (4 min).
